Russell Frank Company’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$4.11M Sell
97,999
-65,835
-40% -$2.58M 0.01% 1457
2015
Q4
$7.27M Buy
163,834
+6,360
+4% +$276K 0.01% 1061
2015
Q3
$7.52M Sell
157,474
-22,378
-12% -$1.23M 0.01% 1040
2015
Q2
$10.5M Buy
179,852
+58,503
+48% +$3.15M 0.02% 947
2015
Q1
$6.13M Buy
+121,349
New +$5.95M 0.01% 1124
2014
Q3
Sell
-48,605
Closed -$1.9M 2856
2014
Q2
$1.9M Sell
48,605
-71,749
-60% -$3.25M ﹤0.01% 1780
2014
Q1
$5.59M Sell
120,354
-118,151
-50% -$5.27M 0.01% 1236
2013
Q4
$10.1M Sell
238,505
-93,058
-28% -$3.54M 0.02% 847
2013
Q3
$11.3M Buy
331,563
+55,130
+20% +$1.8M 0.02% 832
2013
Q2
$8.64M Buy
+276,433
New +$8.97M 0.02% 930

Other funds holding CNMD

Russell Frank Company's CNMD Position: Q1 2016 in Review

Russell Frank Company reduced its CONMED (CNMD) stake by 40% in Q1 2016, selling an estimated $2.58M and leaving 97,999 shares worth $4.11M. The position accounts for 0.01% of the portfolio, ranked #1457.

Russell Frank Company first reported a position in CNMD in Q2 2013 and has held it in 10 quarters since. The position peaked at $11.3M in Q3 2013. 159 funds tracked by Wall St. Rank hold CNMD as of Q1 2016.

  • Russell Frank Company held 97,999 shares of CONMED worth $4.11M as of Q1 2016.
  • Russell Frank Company sold 65,835 CONMED shares in Q1 2016, an estimated $2.58M.
  • CONMED made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1457 holding.
  • Russell Frank Company first reported a position in CONMED in Q2 2013 and has held it in 10 quarters since.
  • Russell Frank Company's CONMED position peaked at $11.3M in Q3 2013.
  • 159 funds tracked by Wall St. Rank held CONMED as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.